Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 2 | 1 | — | — | — | 2 |
Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
Transitional cell carcinoma | D002295 | — | — | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
T-cell lymphoma | D016399 | — | — | 1 | — | — | — | — | 1 |
Hodgkin disease | D006689 | — | C81 | 1 | — | — | — | — | 1 |
Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 1 | — | — | — | — | 1 |
T-cell lymphoma peripheral | D016411 | — | — | 1 | — | — | — | — | 1 |
Drug common name | SAPANISERTIB |
INN | sapanisertib |
Description | 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine is a benzoxazole. |
Classification | Small molecule |
Drug class | serine/threonine kinase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21 |
PDB | — |
CAS-ID | 1224844-38-5 |
RxCUI | — |
ChEMBL ID | CHEMBL3545097 |
ChEBI ID | — |
PubChem CID | 45375953 |
DrugBank | DB11836 |
UNII ID | JGH0DF1U03 (ChemIDplus, GSRS) |